drugset / Trial / NCT01817465

A Study to Demonstrate the Efficacy and Safety of Motilitone®

NCT01817465

Phase 4 Completed 389 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia. The study is conducted with following methods: multi-centers, double blind, randomization, parallel. The subjects will receive Motilitone® or/and Pantoline®.

Timeline

Start
2012-08
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject LUCORIDALINES Unknown 30 mg
Subject LUCORIDALINES Unknown
Comparator Pantoprazole Other / unclassified 40 mg
Comparator Pantoprazole Other / unclassified

Indications